Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer

We retrospectively assessed association of stromal tumor-infiltrating lymphocytes (sTILs) with clinical outcomes and molecular variables reportedly predictive of trastuzumab-benefit in National Surgical Adjuvant Breast and Bowel Project B-31 (N = 2130). sTILs were assessed in 1581 eligible B-31 case...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Natl Cancer Inst
Auteurs principaux: Kim, Rim S, Song, Nan, Gavin, Patrick G, Salgado, Roberto, Bandos, Hanna, Kos, Zuzana, Floris, Giuseppe, den Eynden, Gert G G M Van, Badve, Sunil, Demaria, Sandra, Rastogi, Priya, Fehrenbacher, Louis, Mamounas, Eleftherios P, Swain, Sandra M, Wickerham, D Lawrence, Costantino, Joseph P, Paik, Soonmyung, Wolmark, Norman, Geyer, Charles E, Lucas, Peter C, Pogue-Geile, Katherine L
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Brief Communication
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6695304/
https://ncbi.nlm.nih.gov/pubmed/30888406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djz032
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires